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Background: Th2 cytokine responses are enhanced by all trans retinoic acid (ATRA), the bioavailable form of
vitamin A. Retinoic acid receptor alpha (RARα) is the high affinity receptor for ATRA that mediates these pro-Th2
effects. We have previously characterized two major human Th2 subpopulations: IL-5- Th2 (IL-5-, IL-4+, IL-13+) and
IL-5+ Th2 cells (IL-5+, IL-4+, IL-13+), which represent less and more highly differentiated Th2 cells, respectively. We
hypothesized that the pro-Th2 effects of ATRA may differentially affect these Th2 subpopulations.
Methods: Specific cytokine producing Th2 subpopulations were identified using intracellular cytokine staining.
Proliferation was measured using the Cell Trace Violet proliferation tracking dye. Apoptotic cells were identified
using either annexin-V or active caspase 3 staining. Th2 gene expression was measured using quantitative
polymerase chain reaction.
Results: ATRA increased the output of Th2 cells from house dust mite allergen (HDM) specific short-term cell lines,
and this enhancement was limited to the IL-5+ Th2 subpopulation. Conversely, the RARα antagonist Ro415253
decreased Th2 cell output from these cultures, and this effect was again limited to the IL-5+ Th2 subpopulation.
ATRA and Ro415253 respectively augmented and inhibited Th2 cell proliferation, and this affect was more
pronounced for the IL-5+ vs. IL-5- Th2 subpopulation. ATRA and Ro415253 respectively augmented and inhibited
the expression of IL5 in a significant manner, which was not found for IL4 or IL13.
Conclusions: We report that the reciprocal regulation of Th2 cytokine expression and proliferation by RARα
modulators are largely limited to modulation of IL-5 gene expression and to proliferation of the highly differentiated
IL-5+ Th2 subpopulation. These results suggest that RARα antagonism is a potential means to therapeutically target
allergic inflammation.
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Figure 1 (See legend on next page.)
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Figure 1 Enhancement of Th2 cell output in HDM-stimulated PBMC cultures is reciprocally regulated by RARα modulators. Cell trace
violet (CTV)-labeled PBMCs from allergic asthmatic subjects were stimulated with HDM Ag extract (40 U/ml) for 10d in the presence of ATRA
(RARα agonist), Ro41 (RARα antagonist), or DMSO vehicle control. After 10d cultures were restimulated with PMA and ionomycin and ICCS was
performed. (A) Representative flow plots are shown. Combined results from 3 cultures showing (B) the frequency of CTVlow cells, after gating on
viable HDM proliferated CD3+, CD4+, CD8- cells. Combined results from 3 cultures showing (C) the cell number and (D) percentage of Th2
cytokine producing HDM-expanded T cells. (E) Representative flow plots showing IL-13 vs. IL-5 expression after gating on viable HDM proliferated
CD3+ CD4+ CTVlow cells. Combined results from 3 cultures showing (F) cell number and (G) percentage of of IL-5+ (IL-5+ IL-13+) and IL-5-
(IL-5- IL-13+) Th2 cell populations. Data points represent independent HDM-stimulated PBMC cultures. P-values were generated with 2-way
ANOVA. In B and C, only 2 experiments were performed using IL-4 as an analyte.
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The association between vitamin A and effective im-
mune responses dates back to the early 20th century
when vitamin A was described as an “anti-infective
agent” [1,2]. Large placebo controlled studies in vitamin
deficient populations in developing countries show that
vitamin A supplementation is associated with decreased
childhood mortality from diarrheal disease and measles,
underscoring the critical role for vitamin A in immunity.
Studies on vitamin A deficiency have consistently de-
monstrated an indispensable role for vitamin A in main-
taining host immunity to a variety of pathogens [3-5].
Retinoic acid (RA) is the bioactive form of vitamin A;
all-trans-retinoic acid (ATRA) is the most abundant
form of RA found in the circulation. RA influences
immunity via multiple mechanisms. CD4 T cells are
the immune component most prominently affected by
RA. RA augments the differentiation of inducible T
regulatory cells, which is abrogated both in vitro and
in vivo in either vitamin A deficiency states or using ret-
inoic acid receptor (RAR) deficient mice [5]. In vitamin
A deficient mice, RA restores CD4+ T cell-mediated im-
munity, homeostasis, and activation [4,5]. Previous in-
vestigations suggest that retinoic acid receptor alpha
(RARα) mediates these RA-induced effects on T cells
[5-8]. ATRA exerts its bioactivity via binding to retinoic
acid receptor ligand-activated transcription factors, and
ATRA is a high-affinity ligand for retinoic acid receptor
alpha (RARα). ATRA binding to RAR monomers then
induces hetero-dimerization with retinoid X receptors
(RXRs). The RAR-RXR complex in turn binds to retinoic
acid response elements (RARE) which are present in the
promoters of RA responsive genes and result in gene
activation [9].
Th2 cells were initially characterized as expressing
IL-4, IL-5, and IL-13 [10]. IL-4 is the major factor dri-
ving Th2 differentiation, IgE class switching, and alterna-
tive macrophage activation, whereas IL-13 functions as
an effector molecule that mediates eosinophilic inflam-
mation, airway hyper-responsiveness, and mucus secre-
tion. IL-5 is the major eosinophil-active cytokine and
induces eosinophilopoiesis and eosinophil release from
the bone marrow, enhances eosinophil survival, and actsas a costimulator for eosinophil activation [11,12]. In
vivo, vitamin A is associated with eosinophilic tissue
inflammation, which is both a protective component
of anti-helminth immunity and a major contributor to
asthma pathogenesis. Vitamin A deficiency inhibits para-
site expulsion due to reduced eosinophilia and IL-5
secretion by antigen-specific lymphocytes in vivo, and
vitamin A supplementation restores parasite immunity
[11-14]. Vitamin A deficiency diminishes and high-level
vitamin A supplementation restores Th2 cytokines and
eosinophilia induced by experimental asthma [15].
RARα agonists and RARα antagonists exert opposite
effects on the production of Th2 cytokines by in vitro
stimulated T cells [6,16]. We have recently characterized
two major subpopulations within the Th2 lineage: IL-5+
Th2, which express IL-5, IL-4, and IL-13, and IL-5- Th2
cells, which only express the latter two cytokines [17].
IL-5+ Th2 cells are more highly differentiated and have
greater pro-inflammatory activity than IL-5- Th2 cells
[18,19]. IL-5+ Th2 cells are tightly linked to blood
eosinophilia [20]. Given the known pro-Th2 activity of
RA, we sought to determine if RA drives the diffe-
rentiation of IL-5- Th2 to IL-5+ Th2 cells or otherwise
enhances the generation of IL-5+ Th2 cells. Using a va-
riety of human in vitro Th2 model systems, in this work
we demonstrate the reciprocal regulation of cytokine
production and proliferation by RARα modulators are
specific for the IL-5 gene and these effects are limited to
the highly differentiated IL-5+ Th2 cell subpopulation.
Materials and methods
Subjects
Subjects underwent lymphapheresis (National Institutes
of Health Clinical Center Department of Transfusion
Medicine), and PBMC were isolated as described [17].
Donors used for lymphapheresis included healthy non-
allergic control, eosinophilic gastrointestinal disease and
allergic asthmatic subjects. Allergic asthmatic subjects
had a minimum one-year history of episodic broncho-
spasm relieved by β-agonist medications and three or
more positive skin test responses (≥3 mm) out of a panel
of 10 aeroallergens. The National Institute of Allergy
and Infectious Diseases Institutional Review Board
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subjects signed informed consent.
Cells and culture
For Th2 differentiation, naïve T cells were obtained from
PBMC using the naïve CD4+ T cell isolation kit (Miltenyi
Biotec, Auburn, CA). Naïve cells were Th2 polarized as
published [17]. Th2 polarization cycles were repeated at
weekly intervals, where 1×Th2, 2×Th2, and 3×Th2 repre-
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Figure 2 RARα modulators intrinsically regulate IL-5+ Th2 cell prolife
with the noted stimuli in the presence and absence of ATRA or Ro41. After
performed. (A) Representative flow plot showing total IL-5 vs. CTV (top pan
(bottom panel) subpopulations. Combined results from 5 Th2 cultures show
subpopulations. Data are presented with means (bar) and p values were ge7 d round of stimulation, ATRA/vehicle was added on day
1 and, as replenishment, on day 4 of culture. After dif-
ferentiation, Th2-polarized cells were cryopreserved in
liquid N2, and subsequently thawed and recovered in
complete media containing IL-2 (50–100 U/ml) for at
least 24 h prior to RA experiments.
For proliferation assays, PBMC and Th2-polarized
cells were labeled with 5 μM of Cell Trace Violet prolif-
eration tracking dye (CTV; Invitrogen, Carlsbad, CA) ac-
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ration. In vitro differentiated Th2 cells were CTV labeled and activated
8d cells were restimulated with PMA and ionomycin and ICCS was
el), as well as CTV staining of IL-5+ Th2 (middle panel), and IL-5- Th2
ing CTVlow percentages of (B) total, (C) IL-5+ Th2, and (D) IL-5- Th2
nerated via paired Student’s t test.
Figure 3 (See legend on next page.)
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Figure 3 ATRA does not affect apoptosis of HDM-expanded Th2 cells. CTV labeled PBMCs from allergic asthmatic subjects were cultured
with HDM Ag for 7d with ATRA or DMSO vehicle control. Annexin V staining was measured in the CTVlow (unprolferated) and CTVhigh
(proliferated HDM Ag specific) cells, after first gating on CD4+, 7AAD- lymphocytes. Above, data from a representative experiment. Below,
combined results from 3 independent experiments. The percentage and number of annexin V positive cells are plotted. No statistical differences
were observed by Student’s t test.
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proliferation experiments, both the media control (data
not shown) as well as the allergen activated cultures
yielded 2 CTV bright “negative” peaks (Figure 1A, lower
right hand quadrant). Using 12d antigen activated cultures,
similar doublet “negative” peaks were described by Givan
and Wallace [21,22] and are thought to be an artifact due
to homeostatic proliferation during the prolonged culture.
PBMC proliferation assays were performed using
complete media containing 5% heat inactivated human
AB serum (Invitrogen). Th2 cell proliferation assays
were performed with complete media containing 10%
heat inactivated FBS (Invitrogen). Th2 cell cultures used
for qRT-PCR were performed using media containing
either 10% heat inactivated FBS or 10% charcoal-
stripped heat inactivated FBS (Invitrogen). Similar re-
sults were obtained with both sources of FBS (data not
shown).
All-trans retinoic acid (Sigma, St. Louis, MO) was
reconstituted to 1 mM in DMSO. Ro41-5253 (Ro41,
Enzo Life Sciences, Farmingdale, NY) was reconstituted
to 10 mM in DMSO. For all experiments ATRA, Ro41,
and vehicle (DMSO) were first diluted 1:1000 in 1×PBS
and then added to the culture medium at the de-
sired concentration. For HDM proliferation assays, D.
Pteronyssinus extract (ALK, Round Rock TX) was used
at 40 AU/mL.
Intracellular cytokine staining (ICCS) and flow cytometry
ICCS was performed according to published methods
[17]. Briefly, after activation, cells were washed once
with cold PBS, labeled on ice with Live/Dead Fixable
Aqua Dead Cell Stain (Invitrogen), washed, and fixed in
4% paraformaldehyde (Electron Microscopy Sciences,
Hatfield, PA). Cells were then suspended in PBS with
10% DMSO (Sigma-Aldrich) and cryopreserved at −80°C.
All antibodies and clones used for flow cytometry ana-
lysis have been described [17]. Samples were acquired
on an LSR II flow cytometer (BD Biosciences, Franklin
Lakes, NJ) and analyzed using FlowJo software (Tree
Star, Ashland, OR). Typical forward versus side scatter
identified lymphocytes, and cell doublets were excluded
using forward scatter area versus height. After gating on
viable CD3+, CD4+ cells, data were plotted for various
cytokines based on absolute percentages or cell num-
bers within the respective gate.qRT-PCR
RNA was extracted from cell pellets using the RNeasy
mini kit (Qiagen, Gaithersburg, MD), treated with
DNase (Qiagen), and cDNA was prepared from
100–300 ng RNA using Qscript cDNA Supermix
(Quanta Biosciences, Gaithersburg, MD). qRT-PCR ana-
lysis was performed using the delta Ct method of com-
parison on the Step-One-Plus Real-Time PCR System
Thermal Cycling Block (Applied BioSystems, Carlsbad,
CA). All FAM-MGB-labeled TaqMan probe and primer
sets for IL-4 (Hs00166237_m1), IL-5 (Hs01548712_g1),
IL-13 (Hs00174379_m1), and GAPDH (Hs_03929097_g1)
were purchased from Applied Biosystems.
Statistical analysis
Specific statistical methods used are noted in each Figure
Legend. qRT-PCR fold change was calculated as;
Treated ATRA or Ro41ð Þ
Vehicle control , when this quotient was <1, the nega-
tive of the reciprocal value was calculated as described [23].
Results
Reciprocal regulation of allergen-specific Th2 cytokine
response by RARα modulators
ATRA enhances human Th2 cell cytokine expression in
polyclonally activated T cells [6,16]. To examine the rele-
vance of these findings to allergic disease, we analyzed the
effects of ATRA and the inhibitor Ro415253 (Ro41) on
house dust-mite antigen (HDM) stimulated PBMC from
allergic asthmatic subjects. Cell Trace Violet (CTV) was
used to track CD4+ HDM-specific memory Th2 cells,
which were identified by gating on CTVlow cells that had
proliferated in response to HDM antigen (Figure 1A). Nei-
ther RARα agonist (ATRA), nor RARα antagonist (Ro41)
significantly affected the total number of CD4 T cells pro-
liferating in response to HDM (Figure 1B). However, the
output of HDM-specific proliferated IL-5+ Th2 cells was
dose-dependently enhanced by ATRA, and reciprocally
suppressed by Ro41 (Figure 1C, D).
We have previously characterized two major human
Th2 subpopulations: IL-5- Th2 (IL-5-, IL-4+, IL-13+) and
IL-5+ Th2 cells (IL-5+, IL-4+, IL-13+), which represent
less and more highly differentiated Th2 cells, respectively
[17]. We next analyzed HDM-expanded T cells to deter-
mine how ATRA and Ro41 affect these Th2 cell sub-
populations (Figure 1E). RARα modulators reciprocally
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Figure 4 (See legend on next page.)
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Figure 4 ATRA does not affect caspase-3 activation in CD3 stimulated Th2 cells. Th1 and Th2 cell lines were generated in vitro then
activated with anti-CD3 antibody in presence of ATRA or DMSO vehicle control. Cultures were harvested 4d later and stained for activated
caspase-3. 2xTh2, 3xTh2, etc. represent 2, and 3 serial 7d cycles of Th2 differentiation. Above, flow cytometry plots are shown for all cell lines.
Below, combined results from all cultures noting the percentage of viable (Live/Dead negative) activated caspase-3+ cells (mean +/- SEM).
No statistical differences were observed by paired Student’s t test.
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Th2 subpopulation (Figure 1E, F).
In sum, these data demonstrate that ATRA increases
the output of IL-5+ Th2 cells from allergen driven
cultures.
Intrinsic regulation of IL-5+ Th2 cell proliferation by RARα
modulators
This greater output of allergen specific IL-5+ Th2 cells ob-
served in ATRA treated samples in Figure 1 may be due
to several potential mechanisms, including: enhanced Th2
differentiation, enhanced Th2 cytokine expression, pre-
ferential Th2 proliferation, or inhibition of Th2 apoptosis.
To test if ATRA intrinsically regulates Th2 cell prolifera-
tion, we employed in vitro differentiated human Th2 cells
and examined their proliferation after modulation with
RARα agonist and antagonist treatment (Figure 2). As
expected, T cell receptor (TCR) plus IL-2 stimulation
induced many more generations of cell division than did
IL-2 alone (Figure 2A). In the presence of IL-2 alone ATRA
significantly increased Th2 cell proliferation (Figure 2B).
With maximal activation (anti-CD3, CD28 plus IL-2),
ATRA did not further augment Th2 cell proliferation.
We next examined whether RARα modulation diffe-
rentially affected the proliferation of human Th2 sub-
populations. Among in vitro differentiated Th2 cells,
ATRA augmented IL-2 induced proliferation of both
the IL-5+ and IL-5- subpopulations (Figure 2C, D).
However, Ro41 significantly inhibited the proliferation
of the IL-5+, but not the IL-5- subpopulation. This
Ro41 inhibition further demonstrates the differential re-
sponsiveness of the IL-5+ vs. IL-5- Th2 subpopulations
to RARα modulators.
To further address the cellular mechanisms responsible
for the ATRA mediated increase in IL-5+ Th2 cell output,
we examined ATRA induction of apoptosis. Notably,
ATRA did not alter annexin V expression by CD4+ T cells
in Th2 dominant HDM proliferation cultures (Figure 3).
Additionally, ATRA did not affect caspase-3 activation in
CD3 activated Th1 or Th2 cell lines (Figure 4).
In sum, these data demonstrate that ATRA positively
regulates Th2 cell proliferation via T cell intrinsic me-
chanisms, and that RARα modulators have specificity for
the IL-5+ Th2 subpopulation. Additionally, apoptosis is
not playing a major role in the preferential outgrowth of
IL-5+ Th2 cells induced by ATRA.ATRA inhibits in vitro Th2 cell differentiation
We next examined whether the pro-Th2 effects of
ATRA may be due to augmentation of Th2 differen-
tiation. We hypothesized that the addition of ATRA to
in vitro Th2 cell differentiation cultures would enhance
the frequency and/or kinetics of appearance of Th2
cytokines. Counter to our hypothesis, ATRA inhibited
Th2 cell differentiation of both 2×Th2 and 3×Th2 cells
(Figure 5).
ATRA and Ro41 reciprocally regulate IL5, but not IL4 or
IL13, gene expression
We next tested the hypothesis that RARα modulators
directly regulate Th2 cytokine gene expression via Th2 cell
intrinsic mechanisms. IL-2 activation (in the absence of
TCR signals) increased expression of IL5 message, which
was significantly modulated by ATRA and Ro41, in a re-
ciprocal manner (Figure 6). No differences were observed
in IL4 or IL13 gene expression. These data demonstrate
that in addition to their effects on IL-5+ Th2 cell proli-
feration, RARα modulators directly regulate IL5 gene
expression.
Discussion
Here we report that the pro-Th2 effect induced by reti-
noic acid is primarily a direct result of Th2 cell-intrinsic
regulation of the cytokine IL-5 by RARα. Additionally,
these data demonstrate that RARα regulates the pro-
liferation of IL-5+ but not IL-5- Th2 cells. These results
imply that the highly differentiated IL-5+ effector Th2
cell subpopulation is the primary Th2 cell population
affected by RARα modulators; in contrast, the less dif-
ferentiated IL-5- Th2 cells were significantly less af-
fected. Both the proliferation of IL-5+ Th2 cells as well
as IL5 gene expression was suppressed by the RARα
antagonist Ro41, which suggests that RARα antagonism
might provide a therapeutic approach to inhibit the
function of pathogenic pro-inflammatory IL-5+ Th2
cells.
The ATRA/RARα pathway is a well-known inducer of
Th2 cytokine responses both in vitro and in vivo, working
through both T cell intrinsic and extrinsic mechanisms
[6,16,24]. Our results provide evidence, that among the
three major Th2 cytokines, RARα modulators predo-
minantly regulate IL-5 expression. We and other groups










































































































































Figure 5 (See legend on next page.)
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Figure 5 ATRA inhibits in vitro Th2 cell differentiation. Naïve CD4 T cells were isolated by MACS and differentiated under Th2 culture
conditions in the presence of 1nM ATRA or DMSO vehicle control. (A, B) After 2 and 3 rounds of differentiation (2xTh2 and 3xTh2, respectively)
cells were restimulated with PMA and ionomycin and analyzed by ICCS. (C, D) Percentages and (E, F) mean fluorescence intensity (MFI) of
cytokine positive 2xTh2 (C, E) and 3xTh2 (D, F) cells are plotted from 3 experiments. Data is presented as mean +/- SEM. 2-way ANOVA was
performed and Bonferroni multiple comparisons p values are displayed.
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inflammatory function [17-19]. This current work demon-
strates that some of the pro-Th2 activity of ATRA is due
to increases in Th2 proliferation, particularly that of the
IL-5+ Th2 subpopulation. Notably, despite this overall
pro-IL-5 activity, ATRA did not enhance Th2 differen-
tiation (Figure 5).
Notably, whereas ATRA promoted IL-5+ Th2 re-
sponses, the RARα antagonist Ro41 actually inhibited
IL-5+ Th2 responses. Such inhibition may be due to
Ro41 acting as a neutral antagonist blocking RARα acti-
vation by endogenous ATRA in the cell culture media or
by Ro41 acting as an inverse agonist [25]. Notably, the
latter activity has not been previously reported for Ro41.
Previous human studies showing ATRA-induced Th2
cytokine production have utilized PBMC or CD4 T cells
activated with polyclonal stimuli [6,16]. This study is not-
able for using allergen specific Th2 cells from allergic
asthmatic subjects as well as highly differentiated Th2 cell
lines. The use of such pathogenically relevant Th2 cells
lines confirm and extend previous observations using
mitogen activated PBMC from healthy donors.
This current work showing ATRA augmentation of
pathogenic allergen specific Th2 responses underscores
the potential clinical relevance of these findings. RA
agonists are available both as prescription and over
the counter formulations; these data suggest that RA sup-
plementation may potentially augment Th2 responses and
thus promote allergic disease, as observed in the mouse

























Figure 6 ATRA and Ro41 reciprocally regulate IL5 gene expression. In
cells were cultured with ATRA, Ro41, or DMSO vehicle for 6hrs. The express
change (treated/vehicle) plotted. Th2 cell lines stimulated in the presence o
Paired Student’s t test was used to evaluate the data. Each symbol represeaugment local ATRA levels by the upregulation of retinal-
dehyde dehydrogenase 2, which is required for the bio-
synthesis of retinoic acid. To that end, Shreffler and
colleagues have characterized a previously undescribed
peanut protein that upregulates retinaldehyde dehydro-
genase 2 in myeloid dendritic cells [26].
We studied the intrinsic regulation of Th2 cell func-
tion (proliferation and cytokine production) by reacti-
vating highly differentiated Th2 cells. Since this culture
system utilizes APC-free in vitro differentiated Th2 cells,
the ATRA/Ro41-mediated effects are, by definition, me-
diated by Th2 cell intrinsic mechanisms. Using this
APC-free system, ATRA did not augment Th2 diffe-
rentiation, suggesting that the pro-Th2 effects of RARα
modulation are not through enhanced T cell-intrinsic
effects on Th2 differentiation.
Using either Annexin V or activated caspase 3 to iden-
tify apoptotic cells, RARα modulators did not affect the
frequency of apoptosis (Figures 3 and 4). Taken together,
these findings suggest that ATRA augments Th2 re-
sponses by promoting Th2 cell proliferation and gene
expression and not through differential modulation of
cell death or apoptosis.
An inherent limitation of studies using pharma-
cological inhibitors is the potential for off-target effects.
Indeed, Ro41 has been shown to activate peroxisome
proliferator activated receptor-γ (PPAR-γ) at concen-
trations of 1 μM [27], which is 10-fold greater than the
concentrations used in this study. To further address
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ion of IL-5, IL-4, and IL-13 were determined by qRT-PCR and fold
f IL-2 (50 U/ml) only. Data points represent individual Th2 cell lines.












Exon 4 Exon 3 Exon 2 Exon 1
Exon 4 Exon 3 Exon 2 Exon 1
Exon 4 Exon 3 Exon 2 Exon 1









Human IL-5 Locus (Chr 5)
Rhesus IL-5 Locus (Chr 6)
Mouse IL-5 Locus (Chr 11)








Figure 7 The human IL-5 promoter (0 to -1054) contains a putative retinoic acid response element (RARE). A RARE contains two RARE ½
sites [G(T/G)TCA] and from 1 to 5 spacer nucleotides designated by the “DR” designation. (A) A Schematic representation of the IL-5 locus
between species. The putative RARE location in the IL5p is compared between human, mouse, rat, and rhesus. Alignment of DNA sequence
around the IL5p putative RARE between (B) human and rhesus, and (C) mouse and rat.
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feration, we examined the effect of the PPAR-γ agonist
GW7845 on Th2 cultures. GW7845 did not have any ef-
fect on IL-4, IL-5 or IL-13 expression in these cultures
(data not shown). The relatively low concentration of
Ro41 used in this study as well as the lack of effect of
PPAR-γ activators, make it unlikely that Ro41 was acting
through off-target effects.
This apparent direct regulation of Th2 cytokine gene
expression by RARα prompted us to examine if a puta-
tive retinoic acid response element (RARE) exists in the
promoter regions of Th2 cytokine genes (IL5p, IL4p,
IL13p). We thus analyzed the 10 kb genomic DNA se-
quence of the human IL5, IL4, and IL13 promoters using
the University of California Santa Cruz genome browser.
We identified a single putative RARE (5′-TGGTCA
CAGTTCA-3′) in the human IL5p (−825 to −813) but
not in the human IL4p and IL13p, suggesting that IL5
could be a RARE-responsive gene. The genomic location
of the IL5p putative RARE is comparable betweenhuman and rhesus, and similarly, between mouse and
rat (Figure 7A). The IL5p putative RARE sequence is
identical between human and rhesus (Figure 7B) and
similarly, between mouse and rat (Figure 7C). Subse-
quent studies are needed to verify if this putative RARE
is functionally active.Conclusions
In conclusion, we demonstrate that RARα modulators
act on Th2 cells through multiple mechanisms, inclu-
ding Th2 cell intrinsic augmentation of proliferation and
IL-5 expression. In all experiments, the magnitude of
the effect was most apparent for IL-5 responses. The
potent induction by ATRA and reciprocal inhibition of
IL-5 by Ro41 supports that these effects are mediated
through the RARα receptor. These data demonstrate
that RARα modulation has a major impact on human
Th2 responses and suggests that RARα may be a poten-
tial therapeutic target for anti-Th2 therapy.
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IL13p: Interleukin 13 gene promoter; IL4p: Interleukin 4 gene promoter;
mRNA: Messenger ribonucleic acid; ICCS: Intracellular cytokine staining;
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ANOVA: Analysis of variation; MFI: Mean fluorescence intensity;
SEM: Standard error of mean.
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